In conclusion, this study demonstrates that PD-L1 expression in tumor-associated microvascular endothelial cells is related to tumor staging and identifies the optimal timing for anlotinib to enhance immune cell infiltration in tumors, confirming the findings of our previous research. The gene discussed is CD274; the disease is neoplasm.